Doxepin
In 2016 the American College of Physicians advised that insomnia be treated first by treating comorbid conditions, then with cognitive behavioral therapy and behavioral changes, and then with drugs; doxepin was among those recommended for short-term help maintaining sleep, on the basis of weak evidence. The 2017 American Academy of Sleep Medicine recommendations focused on treatment with drugs were similar. A 2015 AHRQ review of treatments for insomnia had similar findings.
Dark therapy
Dark therapy is the practice of keeping people in complete darkness for periods of time in an attempt to treat psychological conditions. The human body produces melatonin hormone which is responsible for supporting the circadian rhythms. Dark therapy blocks blue wavelength lights to stop the disintegration of melatonin and helps improve the health of human body. It can also relatively minimize headaches, chronic fatigue syndrome, insomnia, and more.